Fifth European Medicines Agency (EMA) and Affordable Medicines Europe bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, 11 September 2026

Ninth European Medicines Agency (EMA) and EFPIA bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 10:30 (CEST) to 16 September 2026, 12:30 (CEST)

Organisation chart: Veterinary Medicines

18th Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 21 September 2026, 09:00 (CEST) to 21 September 2026, 12:30 (CEST)

First European Medicines Agency (EMA) and Active Pharmaceutical Ingredients Committee (APIC) bilateral meeting, European Medicines Agency, Amsterdam, the Netherlands, from 2 September 2026, 15:30 (CEST) to 2 September 2026, 17:30 (CEST)

Human medicines European public assessment report (EPAR): Multaq, dronedarone, Date of authorisation: 25/11/2009, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Aspaveli, pegcetacoplan, Date of authorisation: 13/12/2021, Revision: 14, Status: Authorised

Start of procedure: Type II Variation - Extension of indication under evaluation by the CHMP (26 June 2026 - 23 July 2026)

Start of procedure: Extension of marketing authorisation (26 June 2026 - 23 July 2026)

New leadership team appointments